(Q38223170)

31 August 2017

title

Prevalence of gastroesophageal reflux in cystic fibrosis and implications for lung disease (English)

1 reference

gastroesophageal reflux disease

31 August 2017

0 references

0 references

author name string

Newell Bryce Robinson

series ordinal

1

1 reference

31 August 2017

Emily DiMango

series ordinal

2

1 reference

31 August 2017

publication date

1 July 2014

1 reference

Proceedings of the American Thoracic Society

31 August 2017

published in

1 reference

31 August 2017

volume

11

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

964-968

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

31 August 2017

1 reference

Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Gastroesophageal reflux disease in lung transplant patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Characteristics of gastroesophageal reflux in adults with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Silent acid reflux and asthma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Respiratory pathogens adopt a chronic lifestyle in response to bile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Chest physiotherapy in infants with cystic fibrosis: to tip or not? A five-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Reduction of lipid-laden macrophage index after laparoscopic Nissen fundoplication in cystic fibrosis patients after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Guidelines for the diagnosis and management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Microbial evaluation of proton-pump inhibitors and the risk of pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201401-044FR

10.1513/ANNALSATS.201401-044FR

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference